Friedlander M, Mileshkin L, Lombard J, Frentzas S, et al. Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-expansion stage of a multicentre, open-label, phase I trial. Br J Cancer 2023;129:797-810.
PMID: 37474720